These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 8774069

  • 1. Antitumor activity of zinostatin stimalamer (YM881) in human hepatoma cell lines and VX2 liver tumor-bearing rabbits.
    Tanaka S, Fujihara A, Yamamoto M, Ida H, Ohmi Y, Kitazaki T, Kikuchi Y, Yoshida S, Okamiya H, Numasaki Y, Konno T.
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):155-63. PubMed ID: 8774069
    [Abstract] [Full Text] [Related]

  • 2. [Anti-tumor activity of zinostatin stimalamer (YM 881) examined by human hepatoma cells in vitro and VX2 liver tumor in vivo].
    Tanaka S, Fujihara A, Yamamoto M, Asano M, Ida H, Ohmi Y, Kitazaki T, Kikuchi Y, Yoshida S, Okamiya H.
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):219-26. PubMed ID: 8311492
    [Abstract] [Full Text] [Related]

  • 3. [Antitumor activities of oily suspended YM881 (SMANCS) against VX2 carcinoma].
    Kimura M, Konno T, Ohtsuka N, Mizumachi R, Oda T.
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2183-8. PubMed ID: 2544148
    [Abstract] [Full Text] [Related]

  • 4. [Antitumor activities of oily suspended zinostatin stimalamer (YM 881) against VX2 carcinoma implanted in the liver of rabbits--comparison with another anticancer agent].
    Oda T, Konno T, Ohtsuka N, Kimura M, Mizumachi R.
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2423-8. PubMed ID: 1835341
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antiproliferative effect of YM881 (SMANCS) on glioma cells in vitro.
    Kuratsu J, Takaki S, Kochi M, Mihara Y, Ushio Y.
    Anticancer Res; 1991 Nov; 11(6):1957-61. PubMed ID: 1837980
    [Abstract] [Full Text] [Related]

  • 7. [Antitumor effects of a new antitumor agent, zinostatin stimalamer (YM881)--effects on experimental tumors in vitro and in vivo].
    Numasaki Y, Takahashi K, Masuda E, Nohara C, Maeda H.
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2289-94. PubMed ID: 1834021
    [Abstract] [Full Text] [Related]

  • 8. [Action mechanisms of zinostatin stimalamer (YM881)].
    Tanaka S, Numasaki Y, Maeda H.
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2295-300. PubMed ID: 1834022
    [Abstract] [Full Text] [Related]

  • 9. Antitumor mechanisms of zinostatin stimalamer (YM881).
    Tanaka S, Yamamoto M, Numasaki Y.
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):165-76. PubMed ID: 8774070
    [Abstract] [Full Text] [Related]

  • 10. Changes in the microvascular architecture of colorectal liver metastases following the administration of SMANCS/lipiodol.
    Kuruppu D, Christophi C, Maeda H, O'Brien PE.
    J Surg Res; 2002 Mar; 103(1):47-54. PubMed ID: 11855917
    [Abstract] [Full Text] [Related]

  • 11. [Phase I study of YM881 (zinostatin stimalamer) suspension by hepatic arterial infusion. Research Group for Intra-arterial Infusion Therapy with YM881].
    Taguchi T, Saito T, Ota J, Nakao I, Ohashi K, Nakamura H, Konno T.
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1657-63. PubMed ID: 1651686
    [Abstract] [Full Text] [Related]

  • 12. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
    Konno T, Tabaru K, Isogai M, Nagamitsu A, Oda T.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
    [Abstract] [Full Text] [Related]

  • 13. [Phase II study of YM881 (zinostatin stimalamer) suspension injected into the hepatic artery. Research Group for Intra-arterial Injection Therapy with YM881].
    Taguchi T, Saito T, Ota J, Nakao I, Ohashi K, Nakamura H, Konno T.
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1665-75. PubMed ID: 1714707
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
    Konno T, Maeda H.
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112
    [Abstract] [Full Text] [Related]

  • 18. [Arterial administration of oily anticancer agents dissolved in lipiodol fluid in recurrence of hepatoma after hepatic resection and in metastatic liver cancer].
    Ohtsuka N, Konno T.
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1351-8. PubMed ID: 2837992
    [Abstract] [Full Text] [Related]

  • 19. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
    Takizawa K, Honda M, Obuchi M, Matsuoka S, Shima H, Uchiyama K, Hasebe S, Doai K, Satoh S, Kuniyasu Y.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
    [Abstract] [Full Text] [Related]

  • 20. A phase I study of hepatic arterial infusion chemotherapy with zinostatin stimalamer alone for hepatocellular carcinoma.
    Ishii H, Furuse J, Nagase M, Maru Y, Yoshino M, Hayashi T.
    Jpn J Clin Oncol; 2003 Nov; 33(11):570-3. PubMed ID: 14711981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.